HOME >> BIOLOGY >> NEWS
Europe's largest climate change experiment launched

Dr Heidrun Feuchtmayr and a team from the School of Biological Sciences are conducting a two year project in collaboration with scientists from Belgium, Germany, Norway, Iceland and Denmark, to assess whether a predicted rise in climate temperature for the UK and parts of Europe will increase the toxicity of algae in the country's lakes and ponds.

The project the largest climate change experiment in Europe to date - is based at Ness Botanic Gardens and will involve testing a type of algae in 48 heated water tanks.

Scientists will examine whether a rise in climate temperature will increase the growth of blue-green algae - known as cyanobacteria - many species of which are toxic and can affect fish, snails and other lake dwellers. It has also been known to cause irritation of the skin, headaches and sickness in humans and animals.

Dr Heidrun Feuchtmayr said: "There is limited knowledge about the impact of global climate change on freshwater systems. Many lakes in Europe have suffered problems with blue-green algae through the introduction of fertilisers, discharges from farms and organic chemicals such as washing powder into the water. We now need to look at how these problems may be exacerbated with an increase in temperature."

Pets or livestock drinking toxic lake water can suffer skin irritation and severe disorders involving the circulatory, nervous and digestive systems. In extreme cases, the effects can prove fatal. Humans are also affected by blue-green algae. Military training in lakes containing toxic algae has induced sickness in soldiers, such as vomiting, abdominal pain and sore throats.

Dr Feuchtmayr added: "Climate temperature is predicted to rise by 3 to 5 C in the UK and parts of Europe in the next half century. We will investigate if blue-green algae blooms are more likely to form in heated water tanks and if the toxicity will increase with higher temperatures. We will also assess changes to aquatic comm
'"/>

Contact: Samantha Martin
samantha.martin@liv.ac.uk
151-794-2248
University of Liverpool
18-Jan-2006


Page: 1 2

Related biology news :

1. Major study predicts grim future for Europes seas
2. Europes best young group leaders win EMBO support
3. Europes leading life science researchers are to convene for the first annual EuroBioForum
4. Meet Europes top neurobiologists in Leuven, Belgium
5. Calls for improved screening of colorectal cancer in Europes aging population at ECCO 13
6. EMBO selects Europes best young independent scientists
7. Ossur one of Europes 500 fastest growing companies
8. Europes fishermen should have marine stewardship role, says study
9. Developed/emerging market biotech firms convene at largest-ever meeting with global health focus
10. Press conferences at the years largest physics meeting
11. ICSU and WMO launch the largest polar research program in 50 years

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Europe largest climate change experiment launched

(Date:5/21/2013)... When infections occur in the body, stem cells ... multiplying and differentiating into mature immune cells that ... inflammation can deplete these cell populations, potentially leading ... as cancer. Now, a team of researchers led ... (Caltech) has found that, in mouse models, the ...
(Date:5/21/2013)... phosphatidylserine is a natural food supplement produced from ... and slow memory loss, it,s a popular treatment ... team headed by Prof. Gil Ast and Dr. ... Human Molecular Genetics have discovered that ... involved in degenerative brain disorders, including Parkinson,s disease ...
(Date:5/21/2013)... , Where? Copenhagen, Denmark: Bella Center Congress ... , Why? An annual meeting ... developments, manufacturing and installation, drawing on leading experiences from ... edition from a record of more than 900 abstracts ... plenary and oral presentations, more than 460 visual presentation, ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4
(Date:5/21/2013)... 2013 Custom Learning Designs, Inc.(CLD) ... solution using Tin Can API combined with its ... is a leading developer of training content and ... worldwide. , Tin Can API is a ... and trainers more accurately measure the Return on ...
(Date:5/21/2013)... ISTANBUL , May 21, 2013 ...  European Dialysis and Transplant Association) is the biggest congress ... renal replacement therapy. Nearly 10,000 participants are in ... discuss the latest research findings. New pioneering studies have ... al. "SOLUBLE FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ...
(Date:5/21/2013)... New York , May 21, 2013 ... by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products ... Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, ... 2.4 billion in 2011 and is expected to grow ... to reach an estimated value of USD 4.7 billion ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: